AIM ImmunoTech, Inc. (AIM)
0.57
+0.02
(+3.64%)
USD |
NYAM |
Apr 02, 10:50
AIM ImmunoTech Total Liabilities (Quarterly) : 15.56M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Agenus, Inc. | 504.66M |
| Curis, Inc. | 15.02M |
| Plus Therapeutics, Inc. | 12.33M |
| Windtree Therapeutics, Inc. | 27.58M |
| Viskase Holdings, Inc. | 0.731M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 5.782M |
| Shareholders Equity (Quarterly) | -9.783M |
| Debt to Equity Ratio | -0.5005 |
| Current Ratio | 0.5294 |
| Net Debt Paydown Yield | -9.00% |